Advertisement

Index by Author

August 1999; 48 (8)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Aizawa-Abe, M

    • Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: usefulness of leptin for the treatment of obesity-associated diabetes. Diabetes August 1999 48:1615-1622; doi:10.2337/diabetes.48.8.1615

  2. Aizawa, T

    • Augmentation of Ca2+-stimulated insulin release by glucose and long-chain fatty acids in rat pancreatic islets: free fatty acids mimic ATP-sensitive K+ channel-independent insulinotropic action of glucose. Diabetes August 1999 48:1543-1549; doi:10.2337/diabetes.48.8.1543

  3. Anand, G R

    • Characterization of glucokinase mutations associated with maturity-onset diabetes of the young type 2 (MODY-2): different glucokinase defects lead to a common phenotype. Diabetes August 1999 48:1645-1651; doi:10.2337/diabetes.48.8.1645

  4. Aoki, K

    • Dehydroepiandrosterone suppresses the elevated hepatic glucose-6-phosphatase and fructose-1,6-bisphosphatase activities in C57BL/Ksj-db/db mice: comparison with troglitazone. Diabetes August 1999 48:1579-1585; doi:10.2337/diabetes.48.8.1579

  5. Arcelloni, C

    • Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes August 1999 48:1600-1606; doi:10.2337/diabetes.48.8.1600

B

  1. Baker, L

    • Hyperinsulinism caused by paternal-specific inheritance of a recessive mutation in the sulfonylurea-receptor gene. Diabetes August 1999 48:1652-1657; doi:10.2337/diabetes.48.8.1652

  2. Barton, D E

    • Hyperinsulinism caused by paternal-specific inheritance of a recessive mutation in the sulfonylurea-receptor gene. Diabetes August 1999 48:1652-1657; doi:10.2337/diabetes.48.8.1652

  3. Battezzati, A

    • Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes August 1999 48:1600-1606; doi:10.2337/diabetes.48.8.1600

  4. Bell, G I

    • Characterization of glucokinase mutations associated with maturity-onset diabetes of the young type 2 (MODY-2): different glucokinase defects lead to a common phenotype. Diabetes August 1999 48:1645-1651; doi:10.2337/diabetes.48.8.1645

  5. Bellini, C

    • Relationship between insulin resistance and nonmodulating hypertension: linkage of metabolic abnormalities and cardiovascular risk. Diabetes August 1999 48:1623-1630; doi:10.2337/diabetes.48.8.1623

  6. Bendtzen, K

    • Interleukin-13 prevents autoimmune diabetes in NOD mice. Diabetes August 1999 48:1522-1528; doi:10.2337/diabetes.48.8.1522

  7. Bogardus, C

    • Metabolic factors contributing to increased resting metabolic rate and decreased insulin-induced thermogenesis during the development of type 2 diabetes. Diabetes August 1999 48:1607-1614; doi:10.2337/diabetes.48.8.1607

  8. Bowker-Kinley, M M

    • Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes. Diabetes August 1999 48:1593-1599; doi:10.2337/diabetes.48.8.1593

C

  1. Carlqvist, H

    • Deficiency of phosphofructo-1-kinase/muscle subtype in humans is associated with impairment of insulin secretory oscillations. Diabetes August 1999 48:1557-1561; doi:10.2337/diabetes.48.8.1557

  2. Conget, I

    • Interleukin-13 prevents autoimmune diabetes in NOD mice. Diabetes August 1999 48:1522-1528; doi:10.2337/diabetes.48.8.1522

  3. Cooke, A

    • Interleukin-13 prevents autoimmune diabetes in NOD mice. Diabetes August 1999 48:1522-1528; doi:10.2337/diabetes.48.8.1522

  4. Crawford, M L

    • Cellular immune response to phogrin in the NOD mouse: cloned T-cells cause destruction of islet transplants. Diabetes August 1999 48:1529-1534; doi:10.2337/diabetes.48.8.1529

D

  1. De Cobelli, F

    • Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes August 1999 48:1600-1606; doi:10.2337/diabetes.48.8.1600

  2. Del Maschio, A

    • Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes August 1999 48:1600-1606; doi:10.2337/diabetes.48.8.1600

  3. De Mattia, G

    • Relationship between insulin resistance and nonmodulating hypertension: linkage of metabolic abnormalities and cardiovascular risk. Diabetes August 1999 48:1623-1630; doi:10.2337/diabetes.48.8.1623

  4. Desideri, G

    • Relationship between insulin resistance and nonmodulating hypertension: linkage of metabolic abnormalities and cardiovascular risk. Diabetes August 1999 48:1623-1630; doi:10.2337/diabetes.48.8.1623

  5. Donath, M

    • Hyperinsulinism caused by paternal-specific inheritance of a recessive mutation in the sulfonylurea-receptor gene. Diabetes August 1999 48:1652-1657; doi:10.2337/diabetes.48.8.1652

  6. Dullaart, R P

    • Plasma phospholipid transfer protein activity is lowered by 24-h insulin and acipimox administration: blunted response to insulin in type 2 diabetic patients. Diabetes August 1999 48:1631-1637; doi:10.2337/diabetes.48.8.1631

E

  1. Ebihara, K

    • Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: usefulness of leptin for the treatment of obesity-associated diabetes. Diabetes August 1999 48:1615-1622; doi:10.2337/diabetes.48.8.1615

  2. Eldar-Finkelman, H

    • Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice. Diabetes August 1999 48:1662-1666; doi:10.2337/diabetes.48.8.1662

  3. Elliot, S J

    • IGF-1 decreases collagen degradation in diabetic NOD mesangial cells: implications for diabetic nephropathy. Diabetes August 1999 48:1638-1644; doi:10.2337/diabetes.48.8.1638

  4. Eriksson, J W

    • Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon? Diabetes August 1999 48:1572-1578; doi:10.2337/diabetes.48.8.1572

  5. Eriksson, K F

    • Insulin-regulated mitochondrial gene expression is associated with glucose flux in human skeletal muscle. Diabetes August 1999 48:1508-1514; doi:10.2337/diabetes.48.8.1508

  6. Erlich, H A

    • Association between type 1 diabetes age of onset and HLA among sibling pairs. Diabetes August 1999 48:1658-1661; doi:10.2337/diabetes.48.8.1658

F

  1. Ferri, C

    • Relationship between insulin resistance and nonmodulating hypertension: linkage of metabolic abnormalities and cardiovascular risk. Diabetes August 1999 48:1623-1630; doi:10.2337/diabetes.48.8.1623

G

  1. Gao, Z Y

    • Glucose regulation of glutaminolysis and its role in insulin secretion. Diabetes August 1999 48:1535-1542; doi:10.2337/diabetes.48.8.1535

  2. Gill, R G

    • Cellular immune response to phogrin in the NOD mouse: cloned T-cells cause destruction of islet transplants. Diabetes August 1999 48:1529-1534; doi:10.2337/diabetes.48.8.1529

  3. Glaser, B

    • Hyperinsulinism caused by paternal-specific inheritance of a recessive mutation in the sulfonylurea-receptor gene. Diabetes August 1999 48:1652-1657; doi:10.2337/diabetes.48.8.1652

  4. Gomis, R

    • Interleukin-13 prevents autoimmune diabetes in NOD mice. Diabetes August 1999 48:1522-1528; doi:10.2337/diabetes.48.8.1522

  5. Goodyear, L J

    • 5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes August 1999 48:1667-1671; doi:10.2337/diabetes.48.8.1667

  6. Goran, M I

    • Visceral fat, insulin sensitivity, and lipids in prepubertal children. Diabetes August 1999 48:1515-1521; doi:10.2337/diabetes.48.8.1515

  7. Gower, B A

    • Visceral fat, insulin sensitivity, and lipids in prepubertal children. Diabetes August 1999 48:1515-1521; doi:10.2337/diabetes.48.8.1515

  8. Groop, L

    • Insulin-regulated mitochondrial gene expression is associated with glucose flux in human skeletal muscle. Diabetes August 1999 48:1508-1514; doi:10.2337/diabetes.48.8.1508

  9. Guo, Z

    • Regional postprandial fatty acid metabolism in different obesity phenotypes. Diabetes August 1999 48:1586-1592; doi:10.2337/diabetes.48.8.1586

H

  1. Hansson, M

    • Insulin-regulated mitochondrial gene expression is associated with glucose flux in human skeletal muscle. Diabetes August 1999 48:1508-1514; doi:10.2337/diabetes.48.8.1508

  2. Harrison, L C

    • Cow's milk and type 1 diabetes: the real debate is about mucosal immune function. Diabetes August 1999 48:1501-1507; doi:10.2337/diabetes.48.8.1501

  3. Harris, R A

    • Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes. Diabetes August 1999 48:1593-1599; doi:10.2337/diabetes.48.8.1593

  4. Hashizume, K

    • Augmentation of Ca2+-stimulated insulin release by glucose and long-chain fatty acids in rat pancreatic islets: free fatty acids mimic ATP-sensitive K+ channel-independent insulinotropic action of glucose. Diabetes August 1999 48:1543-1549; doi:10.2337/diabetes.48.8.1543

  5. Haskins, K

    • Interleukin-13 prevents autoimmune diabetes in NOD mice. Diabetes August 1999 48:1522-1528; doi:10.2337/diabetes.48.8.1522

  6. Hattori, M

    • IGF-1 decreases collagen degradation in diabetic NOD mesangial cells: implications for diabetic nephropathy. Diabetes August 1999 48:1638-1644; doi:10.2337/diabetes.48.8.1638

  7. Hebinck, J

    • Deficiency of phosphofructo-1-kinase/muscle subtype in humans is associated with impairment of insulin secretory oscillations. Diabetes August 1999 48:1557-1561; doi:10.2337/diabetes.48.8.1557

  8. Hebrok, M

    • Screening for novel pancreatic genes expressed during embryogenesis. Diabetes August 1999 48:1550-1556; doi:10.2337/diabetes.48.8.1550

  9. Hensrud, D D

    • Regional postprandial fatty acid metabolism in different obesity phenotypes. Diabetes August 1999 48:1586-1592; doi:10.2337/diabetes.48.8.1586

  10. Hirshman, M F

    • 5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes August 1999 48:1667-1671; doi:10.2337/diabetes.48.8.1667

  11. Hollenberg, N K

    • Relationship between insulin resistance and nonmodulating hypertension: linkage of metabolic abnormalities and cardiovascular risk. Diabetes August 1999 48:1623-1630; doi:10.2337/diabetes.48.8.1623

  12. Honeyman, M C

    • Cow's milk and type 1 diabetes: the real debate is about mucosal immune function. Diabetes August 1999 48:1501-1507; doi:10.2337/diabetes.48.8.1501

  13. Hosoda, K

    • Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: usefulness of leptin for the treatment of obesity-associated diabetes. Diabetes August 1999 48:1615-1622; doi:10.2337/diabetes.48.8.1615

  14. Huang, X

    • Insulin-regulated mitochondrial gene expression is associated with glucose flux in human skeletal muscle. Diabetes August 1999 48:1508-1514; doi:10.2337/diabetes.48.8.1508

  15. Hutton, J C

    • Cellular immune response to phogrin in the NOD mouse: cloned T-cells cause destruction of islet transplants. Diabetes August 1999 48:1529-1534; doi:10.2337/diabetes.48.8.1529

I

  1. Inoue, G

    • Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: usefulness of leptin for the treatment of obesity-associated diabetes. Diabetes August 1999 48:1615-1622; doi:10.2337/diabetes.48.8.1615

  2. Inskeep, K

    • Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes. Diabetes August 1999 48:1593-1599; doi:10.2337/diabetes.48.8.1593

  3. Iwai, H

    • Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: usefulness of leptin for the treatment of obesity-associated diabetes. Diabetes August 1999 48:1615-1622; doi:10.2337/diabetes.48.8.1615

J

  1. Jansson, P A

    • Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon? Diabetes August 1999 48:1572-1578; doi:10.2337/diabetes.48.8.1572

  2. Jensen, M D

    • Regional postprandial fatty acid metabolism in different obesity phenotypes. Diabetes August 1999 48:1586-1592; doi:10.2337/diabetes.48.8.1586

  3. Johnson, C M

    • Regional postprandial fatty acid metabolism in different obesity phenotypes. Diabetes August 1999 48:1586-1592; doi:10.2337/diabetes.48.8.1586

K

  1. Kahn, C R

    • Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle. Diabetes August 1999 48:1562-1571; doi:10.2337/diabetes.48.8.1562

  2. Kaneko, T

    • Augmentation of Ca2+-stimulated insulin release by glucose and long-chain fatty acids in rat pancreatic islets: free fatty acids mimic ATP-sensitive K+ channel-independent insulinotropic action of glucose. Diabetes August 1999 48:1543-1549; doi:10.2337/diabetes.48.8.1543

  3. Kaneshiro, M

    • Dehydroepiandrosterone suppresses the elevated hepatic glucose-6-phosphatase and fructose-1,6-bisphosphatase activities in C57BL/Ksj-db/db mice: comparison with troglitazone. Diabetes August 1999 48:1579-1585; doi:10.2337/diabetes.48.8.1579

  4. Kanninen, T

    • Insulin-regulated mitochondrial gene expression is associated with glucose flux in human skeletal muscle. Diabetes August 1999 48:1508-1514; doi:10.2337/diabetes.48.8.1508

  5. Karschnia, E J

    • Characterization of glucokinase mutations associated with maturity-onset diabetes of the young type 2 (MODY-2): different glucokinase defects lead to a common phenotype. Diabetes August 1999 48:1645-1651; doi:10.2337/diabetes.48.8.1645

  6. Kawasaki, S

    • Dehydroepiandrosterone suppresses the elevated hepatic glucose-6-phosphatase and fructose-1,6-bisphosphatase activities in C57BL/Ksj-db/db mice: comparison with troglitazone. Diabetes August 1999 48:1579-1585; doi:10.2337/diabetes.48.8.1579

  7. Kelemen, K

    • Cellular immune response to phogrin in the NOD mouse: cloned T-cells cause destruction of islet transplants. Diabetes August 1999 48:1529-1534; doi:10.2337/diabetes.48.8.1529

  8. Kim, S K

    • Screening for novel pancreatic genes expressed during embryogenesis. Diabetes August 1999 48:1550-1556; doi:10.2337/diabetes.48.8.1550

  9. Komatsu, M

    • Augmentation of Ca2+-stimulated insulin release by glucose and long-chain fatty acids in rat pancreatic islets: free fatty acids mimic ATP-sensitive K+ channel-independent insulinotropic action of glucose. Diabetes August 1999 48:1543-1549; doi:10.2337/diabetes.48.8.1543

  10. Koranyi, L

    • Insulin-regulated mitochondrial gene expression is associated with glucose flux in human skeletal muscle. Diabetes August 1999 48:1508-1514; doi:10.2337/diabetes.48.8.1508

  11. Krebs, E G

    • Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice. Diabetes August 1999 48:1662-1666; doi:10.2337/diabetes.48.8.1662

  12. Krone, W

    • Deficiency of phosphofructo-1-kinase/muscle subtype in humans is associated with impairment of insulin secretory oscillations. Diabetes August 1999 48:1557-1561; doi:10.2337/diabetes.48.8.1557

  13. Kurth-Kraczek, E J

    • 5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes August 1999 48:1667-1671; doi:10.2337/diabetes.48.8.1667

  14. Kurucz, I

    • Insulin-regulated mitochondrial gene expression is associated with glucose flux in human skeletal muscle. Diabetes August 1999 48:1508-1514; doi:10.2337/diabetes.48.8.1508

L

  1. Landaker, E J

    • Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle. Diabetes August 1999 48:1562-1571; doi:10.2337/diabetes.48.8.1562

  2. Landau, H

    • Hyperinsulinism caused by paternal-specific inheritance of a recessive mutation in the sulfonylurea-receptor gene. Diabetes August 1999 48:1652-1657; doi:10.2337/diabetes.48.8.1652

  3. Lange, A J

    • Characterization of glucokinase mutations associated with maturity-onset diabetes of the young type 2 (MODY-2): different glucokinase defects lead to a common phenotype. Diabetes August 1999 48:1645-1651; doi:10.2337/diabetes.48.8.1645

  4. LaPorte, D C

    • Characterization of glucokinase mutations associated with maturity-onset diabetes of the young type 2 (MODY-2): different glucokinase defects lead to a common phenotype. Diabetes August 1999 48:1645-1651; doi:10.2337/diabetes.48.8.1645

  5. Laurila, E

    • Insulin-regulated mitochondrial gene expression is associated with glucose flux in human skeletal muscle. Diabetes August 1999 48:1508-1514; doi:10.2337/diabetes.48.8.1508

  6. LeBoeuf, R C

    • Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice. Diabetes August 1999 48:1662-1666; doi:10.2337/diabetes.48.8.1662

  7. Lehtovirta, M

    • Insulin-regulated mitochondrial gene expression is associated with glucose flux in human skeletal muscle. Diabetes August 1999 48:1508-1514; doi:10.2337/diabetes.48.8.1508

  8. Lenz, O

    • IGF-1 decreases collagen degradation in diabetic NOD mesangial cells: implications for diabetic nephropathy. Diabetes August 1999 48:1638-1644; doi:10.2337/diabetes.48.8.1638

  9. Li, G

    • Glucose regulation of glutaminolysis and its role in insulin secretion. Diabetes August 1999 48:1535-1542; doi:10.2337/diabetes.48.8.1535

  10. Lupia, E

    • IGF-1 decreases collagen degradation in diabetic NOD mesangial cells: implications for diabetic nephropathy. Diabetes August 1999 48:1638-1644; doi:10.2337/diabetes.48.8.1638

  11. Luzi, L

    • Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes August 1999 48:1600-1606; doi:10.2337/diabetes.48.8.1600

M

  1. Masuzaki, H

    • Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: usefulness of leptin for the treatment of obesity-associated diabetes. Diabetes August 1999 48:1615-1622; doi:10.2337/diabetes.48.8.1615

  2. Matschinsky, F M

    • Glucose regulation of glutaminolysis and its role in insulin secretion. Diabetes August 1999 48:1535-1542; doi:10.2337/diabetes.48.8.1535

  3. Melton, D A

    • Screening for novel pancreatic genes expressed during embryogenesis. Diabetes August 1999 48:1550-1556; doi:10.2337/diabetes.48.8.1550

  4. Miller, S P

    • Characterization of glucokinase mutations associated with maturity-onset diabetes of the young type 2 (MODY-2): different glucokinase defects lead to a common phenotype. Diabetes August 1999 48:1645-1651; doi:10.2337/diabetes.48.8.1645

  5. Minty, A

    • Interleukin-13 prevents autoimmune diabetes in NOD mice. Diabetes August 1999 48:1522-1528; doi:10.2337/diabetes.48.8.1522

  6. Mukasa, K

    • Dehydroepiandrosterone suppresses the elevated hepatic glucose-6-phosphatase and fructose-1,6-bisphosphatase activities in C57BL/Ksj-db/db mice: comparison with troglitazone. Diabetes August 1999 48:1579-1585; doi:10.2337/diabetes.48.8.1579

  7. Müller-Wieland, D

    • Deficiency of phosphofructo-1-kinase/muscle subtype in humans is associated with impairment of insulin secretory oscillations. Diabetes August 1999 48:1557-1561; doi:10.2337/diabetes.48.8.1557

N

  1. Nagy, T R

    • Visceral fat, insulin sensitivity, and lipids in prepubertal children. Diabetes August 1999 48:1515-1521; doi:10.2337/diabetes.48.8.1515

  2. Najafi, H

    • Glucose regulation of glutaminolysis and its role in insulin secretion. Diabetes August 1999 48:1535-1542; doi:10.2337/diabetes.48.8.1535

  3. Nakao, K

    • Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: usefulness of leptin for the treatment of obesity-associated diabetes. Diabetes August 1999 48:1615-1622; doi:10.2337/diabetes.48.8.1615

  4. Nicoletti, F

    • Interleukin-13 prevents autoimmune diabetes in NOD mice. Diabetes August 1999 48:1522-1528; doi:10.2337/diabetes.48.8.1522

  5. Nishimura, H

    • Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: usefulness of leptin for the treatment of obesity-associated diabetes. Diabetes August 1999 48:1615-1622; doi:10.2337/diabetes.48.8.1615

  6. Noble, J A

    • Association between type 1 diabetes age of onset and HLA among sibling pairs. Diabetes August 1999 48:1658-1661; doi:10.2337/diabetes.48.8.1658

O

  1. Ogawa, Y

    • Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: usefulness of leptin for the treatment of obesity-associated diabetes. Diabetes August 1999 48:1615-1622; doi:10.2337/diabetes.48.8.1615

  2. Okamura, A

    • Dehydroepiandrosterone suppresses the elevated hepatic glucose-6-phosphatase and fructose-1,6-bisphosphatase activities in C57BL/Ksj-db/db mice: comparison with troglitazone. Diabetes August 1999 48:1579-1585; doi:10.2337/diabetes.48.8.1579

  3. Olesen, B T

    • Insulin-regulated mitochondrial gene expression is associated with glucose flux in human skeletal muscle. Diabetes August 1999 48:1508-1514; doi:10.2337/diabetes.48.8.1508

  4. Ostenson, C G

    • Deficiency of phosphofructo-1-kinase/muscle subtype in humans is associated with impairment of insulin secretory oscillations. Diabetes August 1999 48:1557-1561; doi:10.2337/diabetes.48.8.1557

P

  1. Pagliato, E

    • Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes August 1999 48:1600-1606; doi:10.2337/diabetes.48.8.1600

  2. Patti, M E

    • Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle. Diabetes August 1999 48:1562-1571; doi:10.2337/diabetes.48.8.1562

  3. Perseghin, G

    • Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes August 1999 48:1600-1606; doi:10.2337/diabetes.48.8.1600

  4. Pfeiffer, A

    • Deficiency of phosphofructo-1-kinase/muscle subtype in humans is associated with impairment of insulin secretory oscillations. Diabetes August 1999 48:1557-1561; doi:10.2337/diabetes.48.8.1557

  5. Phillips, J

    • Interleukin-13 prevents autoimmune diabetes in NOD mice. Diabetes August 1999 48:1522-1528; doi:10.2337/diabetes.48.8.1522

  6. Popov, K M

    • Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes. Diabetes August 1999 48:1593-1599; doi:10.2337/diabetes.48.8.1593

  7. Pozza, G

    • Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes August 1999 48:1600-1606; doi:10.2337/diabetes.48.8.1600

  8. Pratley, R E

    • Metabolic factors contributing to increased resting metabolic rate and decreased insulin-induced thermogenesis during the development of type 2 diabetes. Diabetes August 1999 48:1607-1614; doi:10.2337/diabetes.48.8.1607

R

  1. Riemens, S C

    • Plasma phospholipid transfer protein activity is lowered by 24-h insulin and acipimox administration: blunted response to insulin in type 2 diabetic patients. Diabetes August 1999 48:1631-1637; doi:10.2337/diabetes.48.8.1631

  2. Ristow, M

    • Deficiency of phosphofructo-1-kinase/muscle subtype in humans is associated with impairment of insulin secretory oscillations. Diabetes August 1999 48:1557-1561; doi:10.2337/diabetes.48.8.1557

  3. Ryan, F

    • Hyperinsulinism caused by paternal-specific inheritance of a recessive mutation in the sulfonylurea-receptor gene. Diabetes August 1999 48:1652-1657; doi:10.2337/diabetes.48.8.1652

S

  1. Saito, T

    • Dehydroepiandrosterone suppresses the elevated hepatic glucose-6-phosphatase and fructose-1,6-bisphosphatase activities in C57BL/Ksj-db/db mice: comparison with troglitazone. Diabetes August 1999 48:1579-1585; doi:10.2337/diabetes.48.8.1579

  2. Santucci, A

    • Relationship between insulin resistance and nonmodulating hypertension: linkage of metabolic abnormalities and cardiovascular risk. Diabetes August 1999 48:1623-1630; doi:10.2337/diabetes.48.8.1623

  3. Satoh, N

    • Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: usefulness of leptin for the treatment of obesity-associated diabetes. Diabetes August 1999 48:1615-1622; doi:10.2337/diabetes.48.8.1615

  4. Satoh, S

    • Dehydroepiandrosterone suppresses the elevated hepatic glucose-6-phosphatase and fructose-1,6-bisphosphatase activities in C57BL/Ksj-db/db mice: comparison with troglitazone. Diabetes August 1999 48:1579-1585; doi:10.2337/diabetes.48.8.1579

  5. Sato, Y

    • Augmentation of Ca2+-stimulated insulin release by glucose and long-chain fatty acids in rat pancreatic islets: free fatty acids mimic ATP-sensitive K+ channel-independent insulinotropic action of glucose. Diabetes August 1999 48:1543-1549; doi:10.2337/diabetes.48.8.1543

  6. Schreyer, S A

    • Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice. Diabetes August 1999 48:1662-1666; doi:10.2337/diabetes.48.8.1662

  7. Scifo, P

    • Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes August 1999 48:1600-1606; doi:10.2337/diabetes.48.8.1600

  8. Sekihara, H

    • Dehydroepiandrosterone suppresses the elevated hepatic glucose-6-phosphatase and fructose-1,6-bisphosphatase activities in C57BL/Ksj-db/db mice: comparison with troglitazone. Diabetes August 1999 48:1579-1585; doi:10.2337/diabetes.48.8.1579

  9. Shinohara, M M

    • Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice. Diabetes August 1999 48:1662-1666; doi:10.2337/diabetes.48.8.1662

  10. Sluiter, W J

    • Plasma phospholipid transfer protein activity is lowered by 24-h insulin and acipimox administration: blunted response to insulin in type 2 diabetic patients. Diabetes August 1999 48:1631-1637; doi:10.2337/diabetes.48.8.1631

  11. Smith, U

    • Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon? Diabetes August 1999 48:1572-1578; doi:10.2337/diabetes.48.8.1572

  12. Stanley, C A

    • Hyperinsulinism caused by paternal-specific inheritance of a recessive mutation in the sulfonylurea-receptor gene. Diabetes August 1999 48:1652-1657; doi:10.2337/diabetes.48.8.1652

  13. Striker, G E

    • IGF-1 decreases collagen degradation in diabetic NOD mesangial cells: implications for diabetic nephropathy. Diabetes August 1999 48:1638-1644; doi:10.2337/diabetes.48.8.1638

  14. Striker, L J

    • IGF-1 decreases collagen degradation in diabetic NOD mesangial cells: implications for diabetic nephropathy. Diabetes August 1999 48:1638-1644; doi:10.2337/diabetes.48.8.1638

  15. Suga, J

    • Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: usefulness of leptin for the treatment of obesity-associated diabetes. Diabetes August 1999 48:1615-1622; doi:10.2337/diabetes.48.8.1615

T

  1. Testolin, G

    • Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes August 1999 48:1600-1606; doi:10.2337/diabetes.48.8.1600

  2. Thomson, G

    • Association between type 1 diabetes age of onset and HLA among sibling pairs. Diabetes August 1999 48:1658-1661; doi:10.2337/diabetes.48.8.1658

  3. Thornton, P S

    • Hyperinsulinism caused by paternal-specific inheritance of a recessive mutation in the sulfonylurea-receptor gene. Diabetes August 1999 48:1652-1657; doi:10.2337/diabetes.48.8.1652

V

  1. Vaag, A

    • Insulin-regulated mitochondrial gene expression is associated with glucose flux in human skeletal muscle. Diabetes August 1999 48:1508-1514; doi:10.2337/diabetes.48.8.1508

  2. Valdes, A M

    • Association between type 1 diabetes age of onset and HLA among sibling pairs. Diabetes August 1999 48:1658-1661; doi:10.2337/diabetes.48.8.1658

  3. Valenti, M

    • Relationship between insulin resistance and nonmodulating hypertension: linkage of metabolic abnormalities and cardiovascular risk. Diabetes August 1999 48:1623-1630; doi:10.2337/diabetes.48.8.1623

  4. van Tol, A

    • Plasma phospholipid transfer protein activity is lowered by 24-h insulin and acipimox administration: blunted response to insulin in type 2 diabetic patients. Diabetes August 1999 48:1631-1637; doi:10.2337/diabetes.48.8.1631

  5. Vanzulli, A

    • Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes August 1999 48:1600-1606; doi:10.2337/diabetes.48.8.1600

  6. Virkamäki, A

    • Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle. Diabetes August 1999 48:1562-1571; doi:10.2337/diabetes.48.8.1562

  7. Vorgerd, M

    • Deficiency of phosphofructo-1-kinase/muscle subtype in humans is associated with impairment of insulin secretory oscillations. Diabetes August 1999 48:1557-1561; doi:10.2337/diabetes.48.8.1557

W

  1. Waagstein, F

    • Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon? Diabetes August 1999 48:1572-1578; doi:10.2337/diabetes.48.8.1572

  2. Wegmann, D

    • Cellular immune response to phogrin in the NOD mouse: cloned T-cells cause destruction of islet transplants. Diabetes August 1999 48:1529-1534; doi:10.2337/diabetes.48.8.1529

  3. Weyer, C

    • Metabolic factors contributing to increased resting metabolic rate and decreased insulin-induced thermogenesis during the development of type 2 diabetes. Diabetes August 1999 48:1607-1614; doi:10.2337/diabetes.48.8.1607

  4. Williams, G H

    • Relationship between insulin resistance and nonmodulating hypertension: linkage of metabolic abnormalities and cardiovascular risk. Diabetes August 1999 48:1623-1630; doi:10.2337/diabetes.48.8.1623

  5. Winder, W W

    • 5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes August 1999 48:1667-1671; doi:10.2337/diabetes.48.8.1667

  6. Wolf, B A

    • Glucose regulation of glutaminolysis and its role in insulin secretion. Diabetes August 1999 48:1535-1542; doi:10.2337/diabetes.48.8.1535

  7. Wu, P

    • Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes. Diabetes August 1999 48:1593-1599; doi:10.2337/diabetes.48.8.1593

  8. Wysocki, M

    • Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon? Diabetes August 1999 48:1572-1578; doi:10.2337/diabetes.48.8.1572

Y

  1. Yajima, H

    • Augmentation of Ca2+-stimulated insulin release by glucose and long-chain fatty acids in rat pancreatic islets: free fatty acids mimic ATP-sensitive K+ channel-independent insulinotropic action of glucose. Diabetes August 1999 48:1543-1549; doi:10.2337/diabetes.48.8.1543

  2. Yamada, S

    • Augmentation of Ca2+-stimulated insulin release by glucose and long-chain fatty acids in rat pancreatic islets: free fatty acids mimic ATP-sensitive K+ channel-independent insulinotropic action of glucose. Diabetes August 1999 48:1543-1549; doi:10.2337/diabetes.48.8.1543

  3. Yamauchi, K

    • Augmentation of Ca2+-stimulated insulin release by glucose and long-chain fatty acids in rat pancreatic islets: free fatty acids mimic ATP-sensitive K+ channel-independent insulinotropic action of glucose. Diabetes August 1999 48:1543-1549; doi:10.2337/diabetes.48.8.1543

  4. Yki-Järvinen, H

    • Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle. Diabetes August 1999 48:1562-1571; doi:10.2337/diabetes.48.8.1562

  5. Yoshimasa, Y

    • Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: usefulness of leptin for the treatment of obesity-associated diabetes. Diabetes August 1999 48:1615-1622; doi:10.2337/diabetes.48.8.1615

Z

  1. Zaccone, P

    • Interleukin-13 prevents autoimmune diabetes in NOD mice. Diabetes August 1999 48:1522-1528; doi:10.2337/diabetes.48.8.1522

  2. Zheng, F

    • IGF-1 decreases collagen degradation in diabetic NOD mesangial cells: implications for diabetic nephropathy. Diabetes August 1999 48:1638-1644; doi:10.2337/diabetes.48.8.1638

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement